Transitioning from interferon-based to direct antiviral treatment options
A potential shift in barriers and facilitators of treatment initiation among people who use drugs
Bibliographic Data
Environmental health · Hepatitis C · Hepatitis C virus · Population · Prospective cohort study · Virus · Demography · Hepatitis B Virus Studies · Hepatitis C virus research · Liver Disease Diagnosis and Treatment · Medicine · Immunology · Internal Medicine
Reasons for Not Seeking Hepatitis C Treatment among People Who Inject Drugs
Client resistance to hepatitis C treatment initiation in opioid agonist treatment clinics in Sydney, Australia
Socioeconomic stability is associated with lower injection frequency among people with distinct trajectories of injection drug use
Elimination of hepatitis C virus infection among people who use drugs
HCV treatment initiation in the era of universal direct acting antiviral coverage – Improvements in access and persistent barriers
Conceptualising access in the direct-acting antiviral era
Peer outreach point-of-care testing as a bridge to hepatitis C care for people who inject drugs in Toronto, Canada
Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B
Hepatitis C virus treatment for prevention among people who inject drugs
Hepatitis C virus (HCV) disease progression in people who inject drugs (PWID)
Evaluation of two community-controlled peer support services for assessment and treatment of hepatitis C virus infection in opioid substitution treatment clinics
The promise of treatment as prevention for hepatitis C
Elimination of hepatitis C virus infection among PWID
An international perspective on using opioid substitution treatment to improve hepatitis C prevention and care for people who inject drugs
Delivering direct acting antiviral therapy for hepatitis C to highly marginalised and current drug injecting populations in a targeted primary health care setting
Perceptions and self-reported competency related to testing, management and treatment of hepatitis C virus infection among physicians prescribing opioid agonist treatment
Hepatitis C Virus seroconversion among persons who inject drugs in relation to primary care physician visiting
Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use
Assessment and delivery of treatment for hepatitis C virus infection in an opioid substitution treatment clinic with integrated peer-based support in Newcastle, Australia
Rank Correlation Methods
Illness-related stigma, mood and adjustment to illness in persons with hepatitis C
| Unique citing works | 7 |
|---|---|
| Citations per year | 1 |
| Citation span | 2019 - 2023 (5) |
| Citation velocity | historical |
| Highly cited | No |
| Citation types | Neutral: 7 |